Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_842115
Proper Citation: Aviva Systems Biology Cat# ARP38085_T100, RRID:AB_842115
Target Antigen: DR1 (down-regulator of transcription 1 TBP-binding (negative cofactor 2)) (against the N terminal of DR1) (100ug)
Host Organism: rabbit
Clonality: polyclonal
Comments: manufacturer recommendations: IgG WB; ELISA; Western Blot
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for DR1 (down-regulator of transcription 1, TBP-binding (negative cofactor 2)) Antibody (against the N terminal of DR1) (100ug).
No alerts have been found for DR1 (down-regulator of transcription 1, TBP-binding (negative cofactor 2)) Antibody (against the N terminal of DR1) (100ug).
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.